SCHEMBL4924558

SCHEMBL4924558

CN(C)c1ccc(CNC(=O)c2ccc(Cc3cc(Cl)ccc3OCc3ccccc3)o2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 12/20 0.67
HTT P42858 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
MCL1 Q07820 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GNRHR P30968 1/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
GAA P10253 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TP53 P04637 2/20 0.46
THRB P10828 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927464 0.93 PTGER1 (0.77) PTGER1HTTALDH1A1GNRHRLMNA
SCHEMBL4926526 0.83 PTGER1 (0.71) PTGER1CYP1A2CYP3A4GAACYP2D6
SCHEMBL4924180 0.83 PTGER1 (0.71) PTGER1CYP1A2CYP3A4GAACYP2D6
SCHEMBL4923922 0.83 PTGER1 (0.70) PTGER1HTTGNRHRLMNAHPGD
SCHEMBL4924862 0.83 PTGER1 (0.68) PTGER1ALDH1A1LMNAHPGDNPC1
SCHEMBL14008100 0.82 PTGER1 (0.62) PTGER1HTTALDH1A1MAPTTDP1
SCHEMBL4928961 0.82 PTGER1 (0.72) PTGER1CYP1A2CYP3A4GAACYP2D6
SCHEMBL4920186 0.81 PTGER1 (0.71) PTGER1ALDH1A1LMNACYP2C9
SCHEMBL4915784 0.81 PTGER1 (0.74) PTGER1ALDH1A1MAPTHPGDCYP1A2
SCHEMBL4923546 0.81 PTGER1 (1.00) PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885HTT 4678/4885ALDH1A1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.